BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34218880)

  • 1. Artificial Intelligence-Enhanced Electrocardiogram for the Early Detection of Cardiac Amyloidosis.
    Grogan M; Lopez-Jimenez F; Cohen-Shelly M; Dispenzieri A; Attia ZI; Abou Ezzedine OF; Lin G; Kapa S; Borgeson DD; Friedman PA; Murphree DH
    Mayo Clin Proc; 2021 Nov; 96(11):2768-2778. PubMed ID: 34218880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of an electrocardiographic artificial intelligence model for detection of peripartum cardiomyopathy.
    Karabayir I; Wilkie G; Celik T; Butler L; Chinthala L; Ivanov A; Moore Simas TA; Davis RL; Akbilgic O
    Am J Obstet Gynecol MFM; 2024 Apr; 6(4):101337. PubMed ID: 38447673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Artificial Intelligence and Deep Neural Networks in Evaluation of Patients With Electrocardiographically Concealed Long QT Syndrome From the Surface 12-Lead Electrocardiogram.
    Bos JM; Attia ZI; Albert DE; Noseworthy PA; Friedman PA; Ackerman MJ
    JAMA Cardiol; 2021 May; 6(5):532-538. PubMed ID: 33566059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated Detection of Acute Myocardial Infarction Using Asynchronous Electrocardiogram Signals-Preview of Implementing Artificial Intelligence With Multichannel Electrocardiographs Obtained From Smartwatches: Retrospective Study.
    Han C; Song Y; Lim HS; Tae Y; Jang JH; Lee BT; Lee Y; Bae W; Yoon D
    J Med Internet Res; 2021 Sep; 23(9):e31129. PubMed ID: 34505839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction.
    Attia ZI; Noseworthy PA; Lopez-Jimenez F; Asirvatham SJ; Deshmukh AJ; Gersh BJ; Carter RE; Yao X; Rabinstein AA; Erickson BJ; Kapa S; Friedman PA
    Lancet; 2019 Sep; 394(10201):861-867. PubMed ID: 31378392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial Intelligence-Enabled ECG Algorithm to Identify Patients With Left Ventricular Systolic Dysfunction Presenting to the Emergency Department With Dyspnea.
    Adedinsewo D; Carter RE; Attia Z; Johnson P; Kashou AH; Dugan JL; Albus M; Sheele JM; Bellolio F; Friedman PA; Lopez-Jimenez F; Noseworthy PA
    Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008437. PubMed ID: 32986471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Deep-Learning Model to Screen for Hyperkalemia From the Electrocardiogram.
    Galloway CD; Valys AV; Shreibati JB; Treiman DL; Petterson FL; Gundotra VP; Albert DE; Attia ZI; Carter RE; Asirvatham SJ; Ackerman MJ; Noseworthy PA; Dillon JJ; Friedman PA
    JAMA Cardiol; 2019 May; 4(5):428-436. PubMed ID: 30942845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postdevelopment Performance and Validation of the Artificial Intelligence-Enhanced Electrocardiogram for Detection of Cardiac Amyloidosis.
    Harmon DM; Mangold K; Suarez AB; Scott CG; Murphree DH; Malik A; Attia ZI; Lopez-Jimenez F; Friedman PA; Dispenzieri A; Grogan M
    JACC Adv; 2023 Oct; 2(8):. PubMed ID: 38638999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiogram screening for aortic valve stenosis using artificial intelligence.
    Cohen-Shelly M; Attia ZI; Friedman PA; Ito S; Essayagh BA; Ko WY; Murphree DH; Michelena HI; Enriquez-Sarano M; Carter RE; Johnson PW; Noseworthy PA; Lopez-Jimenez F; Oh JK
    Eur Heart J; 2021 Aug; 42(30):2885-2896. PubMed ID: 33748852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial intelligence for early prediction of pulmonary hypertension using electrocardiography.
    Kwon JM; Kim KH; Medina-Inojosa J; Jeon KH; Park J; Oh BH
    J Heart Lung Transplant; 2020 Aug; 39(8):805-814. PubMed ID: 32381339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial Intelligence-Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device.
    Giudicessi JR; Schram M; Bos JM; Galloway CD; Shreibati JB; Johnson PW; Carter RE; Disrud LW; Kleiman R; Attia ZI; Noseworthy PA; Friedman PA; Albert DE; Ackerman MJ
    Circulation; 2021 Mar; 143(13):1274-1286. PubMed ID: 33517677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis.
    Porcari A; Rossi M; Cappelli F; Canepa M; Musumeci B; Cipriani A; Tini G; Barbati G; Varrà GG; Morelli C; Fumagalli C; Zampieri M; Argirò A; Vianello PF; Sessarego E; Russo D; Sinigiani G; De Michieli L; Di Bella G; Autore C; Perfetto F; Rapezzi C; Sinagra G; Merlo M
    Eur J Heart Fail; 2022 Jul; 24(7):1227-1236. PubMed ID: 35509181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-of-care screening for heart failure with reduced ejection fraction using artificial intelligence during ECG-enabled stethoscope examination in London, UK: a prospective, observational, multicentre study.
    Bachtiger P; Petri CF; Scott FE; Ri Park S; Kelshiker MA; Sahemey HK; Dumea B; Alquero R; Padam PS; Hatrick IR; Ali A; Ribeiro M; Cheung WS; Bual N; Rana B; Shun-Shin M; Kramer DB; Fragoyannis A; Keene D; Plymen CM; Peters NS
    Lancet Digit Health; 2022 Feb; 4(2):e117-e125. PubMed ID: 34998740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of hypertrophic cardiomyopathy by an artificial intelligence electrocardiogram in children and adolescents.
    Siontis KC; Liu K; Bos JM; Attia ZI; Cohen-Shelly M; Arruda-Olson AM; Zanjirani Farahani N; Friedman PA; Noseworthy PA; Ackerman MJ
    Int J Cardiol; 2021 Oct; 340():42-47. PubMed ID: 34419527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Light chain and transthyretin cardiac amyloidosis: Clinical characteristics, natural history and prognostic factors.
    Barge-Caballero G; Vázquez-García R; Barge-Caballero E; Couto-Mallón D; Paniagua-Martín MJ; Barriales-Villa R; Piñón-Esteban P; Bouzas-Mosquera A; Pombo-Otero J; Debén-Ariznavarreta G; Vázquez-Rodríguez JM; Crespo-Leiro MG
    Med Clin (Barc); 2021 Apr; 156(8):369-378. PubMed ID: 32591181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive risk stratification of patients with transthyretin amyloidosis.
    Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
    JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing and Mitigating Bias in Medical Artificial Intelligence: The Effects of Race and Ethnicity on a Deep Learning Model for ECG Analysis.
    Noseworthy PA; Attia ZI; Brewer LC; Hayes SN; Yao X; Kapa S; Friedman PA; Lopez-Jimenez F
    Circ Arrhythm Electrophysiol; 2020 Mar; 13(3):e007988. PubMed ID: 32064914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, Incidence, and Impact on Mortality of Conduction System Disease in Transthyretin Cardiac Amyloidosis.
    Donnellan E; Wazni OM; Saliba WI; Hanna M; Kanj M; Patel DR; Wilner B; Kochar A; Jaber WA
    Am J Cardiol; 2020 Aug; 128():140-146. PubMed ID: 32650908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.